Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands		Common Stock		Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019		$ 3	[1]	$ (768)	$ 87,199	$ (186,372)	$ (99,938)
Balance (in Shares) at Dec. 31, 2019		34,140,909	[1]	(90,302)
Stock-based compensation			[1]		13,681		13,681
Accretion of stock issuance costs and dividends on Series H, I and J contingently redeemable preferred stock			[1]		(96,974)		(96,974)
Exercise of stock options, net of withholding taxes			[1]		(11,883)		(11,883)
Exercise of stock options, net of withholding taxes (in Shares)	[1]	2,643,694
Exercise of warrants			[1]		98		98
Exercise of warrants (in Shares)	[1]	1,210,247
Redemption of Series H preferred stock through issuance of common stock		$ 1	[1]		106,642		106,643
Redemption of Series H preferred stock through issuance of common stock (in Shares)	[1]	10,600,347
Retirement of treasury stock			[1]	$ 768	(768)
Retirement of treasury stock (in Shares)		(90,302)	[1]	90,302
Contingent shares issuance liabilities associated with the Merger and Recapitalization			[1]		(16,687)		(16,687)
Merger and Recapitalization, net of transaction costs		$ 4	[1]		209,969		209,973
Merger and Recapitalization, net of transaction costs (in Shares)	[1]	26,393,485
Net loss			[1]			(49,847)	(49,847)
Balance at Dec. 31, 2020		$ 8	[1]		291,277	(236,219)	55,066
Balance (in Shares) at Dec. 31, 2020	[1]	74,898,380
Stock-based compensation			[1]		19,042		19,042
Release of RSUs			[1]
Release of RSUs (in Shares)	[1]	1,974,762
Exercise of stock options			[1]		85		85
Exercise of stock options (in Shares)	[1]	30,865
Issuance of shares through employee stock purchase plan			[1]		235		235
Issuance of shares through employee stock purchase plan (in Shares)	[1]	143,353
Surrender of shares released through vested RSUs			[1]
Surrender of shares released through vested RSUs (in Shares)	[1]	(726,153)
Common stock issued as consideration for business acquisition (Access Physicians)		$ 1	[1]		91,693		91,694
Common stock issued as consideration for business acquisition (Access Physicians) (in Shares)	[1]	13,753,387
Issuance of Class A Common stock, net of issuance costs		$ 1	[1]		51,544		51,545
Issuance of Class A Common stock, net of issuance costs (in Shares)	[1]	9,200,000
Net loss			[1]			(50,542)	(50,542)
Balance at Dec. 31, 2021		$ 10	[1]		$ 453,876	$ (286,761)	$ 167,125
Balance (in Shares) at Dec. 31, 2021	[1]	99,274,594

[1] As part of the Merger Transaction (as disclosed in Note 18), all per share information has been retroactively adjusted using an exchange ratio of 0.4047 per share.